Cardiology Update 2019
Cardiology Update 2019 – Meet the Experts
The Role of NOACs in the Management of Ischaemic Heart Disease and
Prevention of Cardiovascular Events
Prof Juan Carlos Kaski DSc, MD (Hons), FRCP, FESC, FACC, FAHA
Professor of Cardiovascular Science, Molecular and Clinical Science Research Institute
St George’s, University of London
What this meeting is about
Cardiology Update 2019 – Meet the Experts – will provide insight into the role of NOACs in the prevention of cardiovascular events in patients with ischaemic heart disease. The meeting aims at discussing results of recent trials testing the effects of NOAC administration in patients with stable coronary artery disease and peripheral artery disease. The programme will address the role of the coagulation system as a pathogenic factor in the development of cardiovascular events and as therapeutic target.
Cardiology Update is a highly interactive meeting and this year we plan to have more time than that in previous meetings, for questions and answers following the different talks. There will also be clinical case presentations and discussion.
1- To gain insight into the role of the coagulation pathway in coronary artery and peripheral artery disease progression;
2- To understand the effects of anticoagulant therapy in the prevention of major cardiovascular events;
3- To gain insight into the effects of combined anticoagulant and antithrombotic therapies in the prevention of peripheral vascular disease and its complications;
4- To discuss the role of platelets and diabetes in vascular disease progression and clinical outcomes and how to prevent events;
5- To create an interactive forum where faculty members and attendees can have fruitful face to face discussions;
6- To discuss clinical cases that provide insight into novel cardiovascular disease prevention strategies.
Target audience & registration fees
This scientific programme addresses topics that will be of interest to cardiologists, vascular disease specialists, vascular surgeons, haematologists, diabetologists and general practitioners with an interest in cardiovascular disease, health professionals involved in cardiovascular risk assessment and management, and trainees in the areas above.
The meeting is offered free of charge and is limited to 60 attendees. We will operate a first-come, first-served basis.
An application for CPD approval has been submitted to the Federation of the Royal Colleges of Physicians of the United Kingdom. Information will be updated here once credits are confirmed.
Auspices, Sponsorship and Disclaimers
The programme has been devised exclusively and independently by the meeting’s scientific committee.
This scientific meeting is held under the auspices of the Angina Awareness Initiative from the ESC Working Group on Cardiovascular Pharmacotherapy and the International Society of Cardiovascular Pharmacotherapy (ISCP).
Bayer UK has provided an unrestricted educational grant to partially cover organisational costs and has had no input into the agenda or content of this educational activity.